MOOS WALTER H 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 24, 2026
Insider Transaction Report
Form 4
MOOS WALTER H
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-20$24.00/sh+4,000$96,000→ 16,722 total - Sale
Common Stock
2026-02-20$36.36/sh−4,000$145,440→ 12,722 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F2]2026-02-20−4,000→ 0 totalExercise: $24.00Exp: 2026-05-11→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F2]The shares vested monthly over twelve (12) months from the grant date of May 11, 2016.
Signature
/s/ Raymond Furey (Attorney-in-Fact)|2026-02-24